137 related articles for article (PubMed ID: 30861556)
21. Identification of Barrett's esophagus in relatives by endoscopic screening.
Chak A; Faulx A; Kinnard M; Brock W; Willis J; Wiesner GL; Parrado AR; Goddard KA
Am J Gastroenterol; 2004 Nov; 99(11):2107-14. PubMed ID: 15554988
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
[TBL] [Abstract][Full Text] [Related]
23. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
24. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy.
Thota PN; Vennalaganti P; Vennelaganti S; Young P; Gaddam S; Gupta N; Lieberman D; Sampliner R; Falk GW; Mathur S; Kennedy K; Cash BD; Moawad F; Bansal A; Spaander MC; Bruno MJ; Vargo J; Sharma P
Gastroenterology; 2017 Apr; 152(5):987-992. PubMed ID: 27988383
[TBL] [Abstract][Full Text] [Related]
25. A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia.
Picardo SL; O'Brien MP; Feighery R; O'Toole D; Ravi N; O'Farrell NJ; O'Sullivan JN; Reynolds JV
Dis Esophagus; 2015; 28(2):121-6. PubMed ID: 24428806
[TBL] [Abstract][Full Text] [Related]
26. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
27. Patients With Barrett's Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer.
Kestens C; Offerhaus GJ; van Baal JW; Siersema PD
Clin Gastroenterol Hepatol; 2016 Jul; 14(7):956-962.e1. PubMed ID: 26748222
[TBL] [Abstract][Full Text] [Related]
28. Barrett's esophagus.
Falk GW
Gastroenterology; 2002 May; 122(6):1569-91. PubMed ID: 12016424
[TBL] [Abstract][Full Text] [Related]
29. Familial clustering of Barrett's esophagus and esophageal adenocarcinoma in a European cohort.
Verbeek RE; Spittuler LF; Peute A; van Oijen MG; Ten Kate FJ; Vermeijden JR; Oberndorff A; van Baal JW; Siersema PD
Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1656-63.e1. PubMed ID: 24480679
[TBL] [Abstract][Full Text] [Related]
30. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
31. Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival?
Dellon ES; Shaheen NJ
J Clin Oncol; 2005 Jul; 23(20):4478-82. PubMed ID: 16002837
[TBL] [Abstract][Full Text] [Related]
32. How far to go? Screening and surveillance in Barrett's esophagus.
Lieberman DA; Sampliner RE
Am J Manag Care; 2001 Feb; 7(1 Suppl):S19-26. PubMed ID: 11225349
[TBL] [Abstract][Full Text] [Related]
33. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
Schlottmann F; Molena D; Patti MG
Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
[TBL] [Abstract][Full Text] [Related]
34. Surveillance of patients with long-segment Barrett's esophagus: A multicenter prospective cohort study in Japan.
Matsuhashi N; Sakai E; Ohata K; Ishimura N; Fujisaki J; Shimizu T; Iijima K; Koike T; Endo T; Kikuchi T; Inayoshi T; Amano Y; Furuta T; Haruma K; Kinoshita Y
J Gastroenterol Hepatol; 2017 Feb; 32(2):409-414. PubMed ID: 27416773
[TBL] [Abstract][Full Text] [Related]
35. Improving screening practices for Barrett's esophagus.
Shaheen NJ; Palmer LB
Surg Oncol Clin N Am; 2009 Jul; 18(3):423-37. PubMed ID: 19500734
[TBL] [Abstract][Full Text] [Related]
36. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
[TBL] [Abstract][Full Text] [Related]
37. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
38. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.
Bytzer P; Christensen PB; Damkier P; Vinding K; Seersholm N
Am J Gastroenterol; 1999 Jan; 94(1):86-91. PubMed ID: 9934736
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy.
Balasubramanian G; Singh M; Gupta N; Gaddam S; Giacchino M; Wani SB; Moloney B; Higbee AD; Rastogi A; Bansal A; Sharma P
Am J Gastroenterol; 2012 Nov; 107(11):1655-61. PubMed ID: 23032983
[TBL] [Abstract][Full Text] [Related]
40. [Gastroesophageal reflux disease and malignancy].
Richert Z; Robaszkiewicz M
Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
